Induction of PrP^Sc-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease

REFERENCES

• Saunders SE, Bartelt-Hunt SL, Bartz JC. Occurrence, transmission, ad zoonotic potential of chronic wasting disease. Emerg Infect Dis. 2012;18:369–76. doi:10.3201/eid1803.110685. PMID:22377159.
   PubMed Web of Science ®Google Scholar
• Lee YH, Sohn HJ, Kim MJ, Kim HJ, Lee WY, Yun EI, Tark DS, Cho IS, Balachandran A. Strain characterization of the Korean CWD cases in 2001 and 2004. J Vet Med Sci. 2013;75:95–98. Epub 2012 Aug 28. doi:10.1292/jvms.12-0077. PMID:22972463.
   PubMed Web of Science ®Google Scholar
• Benestad SL, Mitchell G, Simmons M, Ytrehus B, Vikoren T. First case of chronic wasting disease in Europe in a Norwegian free-ranging reindeer. Vet Res. 2016;1:88. doi:10.1186/s13567-016-0375-4
   Web of Science ®Google Scholar
• Belay ED, Gambetti P, Schonberger LB, Parchi P, Lyon DR, Capellari S, McQuiston JH, Bradley K, Dowdle G, Crutcher JM, et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol. 2001;58:1673–78. doi:10.1001/archneur.58.10.1673. PMID:11594928.
   PubMed Web of Science ®Google Scholar
• Czub S. First evidence of intracranial and peroral transmission of Chronic Wasting Disease (CWD) into Cynomolgus macaques: A work in progress. Prion 2017 Deciphering Neurodegenerative Disorders; 2017 May 2017; Edinburgh, Scotland.
   Google Scholar
• Mateus-Pinilla N, Weng HY, Ruiz MO, Shelton P, Novakofski J. Evaluation of a wild white-tailed deer population management program for controlling chronic wasting disease in Illinois, 2003–2008. Prev Vet Med. 2013;110:541–48. doi:10.1016/j.prevetmed.2013.03.002. PMID:23558033.
   PubMed Web of Science ®Google Scholar
• Uehilnger FD, Johnston AC, Bollinger TK, Waldner CL. Systematic review of management strategies to control chronic wasting disease in wild deer populations in North America. BMC Vet Res. 2016;12:173. doi:10.1186/s12917-016-0804-7. PMID:27549119.
   PubMed Web of Science ®Google Scholar
• Almberg ES, Cross PC, Johnson CJ, Heisey DM, Richards BJ. Modeling routes of chronic wasting disease transmission: Environmental prion persistence promotes deer population decline and extinction. PLoS One. 2011;6:e19896. Epub 2011 May 13. doi:10.1371/journal.pone.0019896. PMID:21603638.
   PubMed Web of Science ®Google Scholar
• Seidel B, Thomzig A, Buschmann A, Groschup MH, Peters R, Beekes M, Terytze K. Scrapie agent (strain 263) can transmit disease via the oral route after persistence in soil for years. PLoS One. 2007;9:e435. doi:10.1371/journal.pone.0000435
   Web of Science ®Google Scholar
• Pritzkow S, Morales R, Moda F, Khan U, Telling GC, Hoover E, Soto C. Grass plants bind, retain, uptake, and transport infectious prions. Cell Res. 2015;11:1168–75.
   Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–44. doi:10.1126/science.6801762. PMID:6801762.
   PubMed Web of Science ®Google Scholar
• Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A. 2001;98:9295–9. doi:10.1073/pnas.151242598. PMID:11470893.
   PubMed Web of Science ®Google Scholar
• Perrier V, Solassol J, Crozet C, Frobert Y, Mourton-Gilles C, Grassi J, Lehmann S. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J Neurochem. 2004;89:454–63. doi:10.1111/j.1471-4159.2004.02356.x. PMID:15056288.
   PubMed Web of Science ®Google Scholar
• Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 2001;412:739–43. doi:10.1038/35089090. PMID:11507642.
   PubMed Web of Science ®Google Scholar
• Taschuk R, Van der Merwe J, Marciniuk K, Potter A, Cashman N, Griebel P, Napper S. In vitro neutralization of prions with PrP(Sc)-specific antibodies. Prion. 2015;9:292–303. doi:10.1080/19336896.2015.1071761. PMID:26284508.
   PubMed Web of Science ®Google Scholar
• Sigurdsson EM, Brown DR, Daniels M, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T. Immunization delays the onset of prion disease in mice. Am J Pathol. 2002;161:13–7. doi:10.1016/S0002-9440(10)64151-X. PMID:12107084.
   PubMed Web of Science ®Google Scholar
• Sigurdsson EM, Sy M-S, Li R, Scholtzova H, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci Lett. 2003;336:185–7. doi:10.1016/S0304-3940(02)01192-8. PMID:12505623.
   PubMed Web of Science ®Google Scholar
• Moda F, Vimercati C, Campagnani I, Ruggerone M, Giaccone G, Morbin M, Zentilin L, Giacca M, Zucca I, Legname G, et al. Brain delivery of AAv9 expressing an anti-PrP monovalent antibody delays prion disease in mice. Prion. 2012;6:383–90. doi:10.4161/pri.20197. PMID:22842862.
   PubMed Web of Science ®Google Scholar
• Koller MF, Grau T, Christen P. Induction of antibodies against murine full-length prion protein in wild-type mice. J Neuroimmunol. 2002;132:113–6. doi:10.1016/S0165-5728(02)00316-8. PMID:12417440.
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Goni F. Immunomodulation for prion and prion-related diseases. Expert Rev Vaccines. 2010;6:75–85.
   Google Scholar
• Marciniuk K, Taschuk R, Napper S. Evidence for prion-like mechanisms in several neurodegenerative diseases: Potential implications for immunotherapy. Clin Dev Immunol. 2013;2013:473706. doi:10.1155/2013/473706. PMID:24228054.
   PubMed Web of Science ®Google Scholar
• Xanthopoulos K, Lagoudaki R, Kontana A, Kyratsous C, Panagiotidis C, Grigoriadis N, Yiangou M, Sklaviadis T. Immunization of recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanism. PLoS One. 2013;8:e59143. doi:10.1371/journal.pone.0059143. PMID:23554984.
   PubMed Web of Science ®Google Scholar
• Taschuk R, Marciniuk K, Maattanen P, Madampage C, Hedlin P, Potter A, Lee J, Cashman N, Griebel PJ, Napper S. Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope. Prion. 2014;8:51–59. doi:10.4161/pri.27962. PMID:24509522.
   PubMed Web of Science ®Google Scholar
• Bade S, Baier M, Boetel T, Frey A. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired bovine spongiform encephalopathy. Vaccine. 2006;24:1242–53. doi:10.1016/j.vaccine.2005.12.051. PMID:16455168.
   PubMed Web of Science ®Google Scholar
• Goñi F, Mathiason CK, Yim L, Wong K, Hayes-Klug J, Nalls A, Peyser D, Estevez V, Denkers N, Xu J, et al. Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease. Vaccine. 2015;33:726–33. doi:10.1016/j.vaccine.2014.11.035. PMID:25539804.
   PubMed Web of Science ®Google Scholar
• Goñi F, Prelli F, Schreiber F, Scholtzova H, Chung E, Kascsak R, Brown DR, Sigurdsson EM, Chabalgoity JA, Wisniewski T. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience. 2008;15:679–86. Epub 2008 Mar 6. doi:10.1016/j.neuroscience.2008.02.051
   Web of Science ®Google Scholar
• Goñi F, Knudsen E, Schreiber F, Scholtzova H, Pankiewicz J, Carp R, Meeker HC, Rubenstein R, Brown DR, Sy MS, et al. Mucosal vaccination delays or prevents prion infection via an oral route. Neurosci. 2005;133:413–21. doi:10.1016/j.neuroscience.2005.02.031
   PubMed Web of Science ®Google Scholar
• Schwarz A, Krätke O, Burwinkel M, Riemer C, Schultz J, Henklein P, Bamme T, Baier M. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett. 2003;350:187–9. doi:10.1016/S0304-3940(03)00907-8. PMID:14550926.
   PubMed Web of Science ®Google Scholar
• Magri G, Clerici M, Dall'Ara P, Biasin M, Caramelli M, Casalone C, Giannino ML, Longhi R, Piacentini L, Della Bella S, et al. Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. Vaccine. 2005;23:2862–8. doi:10.1016/j.vaccine.2004.11.067. PMID:15780734.
   PubMed Web of Science ®Google Scholar
• Solforosi L, Criado JR, McGavern DB, Wirz S, Sánchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science. 2004;303:1514–6. doi:10.1126/science.1094273. PMID:14752167.
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science. 2000;289:1925–8. doi:10.1126/science.289.5486.1925. PMID:10988071.
   PubMed Web of Science ®Google Scholar
• Arsenault RJ, Li Y, Potter A, Griebel PJ, Kusalik A, Napper S. Induction of ligand-specific PrP (C) signaling in human neuronal cells. Prion. 2012;6(5):477–88. doi:10.4161/pri.21914. PMID:22918447.
   PubMed Web of Science ®Google Scholar
• Sonati T, Reimann RR, Falsig J, Baral PK, O'Connor T, Hornemann S, Yaganoglu S, Li B, Herrmann US, Wieland B, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature. 2013;501:102–09 doi:10.1038/nature12402. PMID:23903654.
   PubMed Web of Science ®Google Scholar
• Reimann RR, Sonati T, Hornemann S, Herrmann US, Arand M, Hawke S, Aguzzi A. Differential toxicity of antibodies to the prion protein. PLoS Pathog. 2016;12(1):e1005401. ppat.1005401. doi:10.1371/journal.ppat.1005401. PMID:26821311.
   PubMed Web of Science ®Google Scholar
• Herrmann US, Sonati T, Falsig J, Reimann RR, Dametto P, O'Connor T, Li B, Lau A, Hornemann S, Sorce S, et al. Prion infections and Anti-PrP antibodies trigger converging neurotoxic pathways. PLoS Pathog. 2015;11(2):e1004662. doi:10.1371/journal.ppat.1004662. PMID:25710374.
   PubMed Web of Science ®Google Scholar
• Hedlin PD, Cashman NR, Li L, Gupta J, Babiuk LA, Potter AA, Griebel P, Napper S. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)- specific antibody responses. Vaccine. 2010;28:981–8. doi:10.1016/j.vaccine.2009.10.134. PMID:19925901.
   PubMed Web of Science ®Google Scholar
• Marciniuk K, Maattanen P, Taschuk R, Airey D, Potter A, Cashman NR, Griebel P, Napper S. Development of a Multivalent, PrPSc-specific prion vaccine through rational optimization of three disease-specific epitopes. Prion. 2014;32:1988–97.
   Google Scholar
• Gossert AD, Bonjour S, Lysek DA, Fiorito F, Wuthrich K. Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A. 2005;102:646–50. doi:10.1073/pnas.0409008102. PMID:15647363.
   PubMed Web of Science ®Google Scholar
• Uger MD, Chai V, Ciolfi V, Chen H, Plawinski E, Mutukura T, Sage A, Demers R, Lau L, Lee P, et al. Abstract 4636: AMF-1c-120: An antibody specific for misfolded prion protein expressed on ovarian cancer cells. Exp Mol Ther. 2013;73:4636–36.
   Google Scholar
• Mahl P, Clinquet F, Guiot AL, Niin E, Fournials E, Saint-Jean N, Aubert M, Rupprecht CE, Gueguen S. Twenty-year experience of the oral rabies vaccine SAG2 in wildlife: A global review. Vet Res. 2014;45:77. doi:10.1186/s13567-014-0077-8. PMID:25106552.
   PubMed Web of Science ®Google Scholar
• Sterner RT, Meltzer MI, Shwiff SA, Slate D. Tactics and economics of wildlife oral rabies vaccination, Canada and the United States. Emerg Infect Dis. 2009;15:1176–84. doi:10.3201/eid1508.081061. PMID:19757549.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Sharma S, Walunj SS, Chaturvedi VK, Raut AA, Patial S, Rai A, Pandey KD, Saini M. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus. Vet Microbiol. 2005;108:207–14. doi:10.1016/j.vetmic.2005.04.007. PMID:15916870.
   PubMed Web of Science ®Google Scholar
• Smith ME, Koser M, Xiao S, Siler C, McGettigen JP, Calkins C, Pomerantz RJ, Dietzschold B, Schnell MJ. Rabies virus glycoprotein as a carrier for anthrax protective antigen. Virol. 2006;30:344–56. doi:10.1016/j.virol.2006.05.010
   Web of Science ®Google Scholar
• Taschuk R, Griebel P, Napper S. Carrier protein significantly alters the magnitude, duration and type of antibody response to a peptide epitope from a self-protein. J Immol and Vacc. 2015;1(1):101.
   Google Scholar
• Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, et al. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J Virol. 1997;71:8531–41. PMID:9343211.
   PubMed Web of Science ®Google Scholar
• Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San S, Rood D, Grubman MJ, Silbart LK. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine. Vaccine. 2013;26:2302–09. doi:10.1016/j.vaccine.2013.02.060
   Web of Science ®Google Scholar
• Griscelli F, Opolon P, Saulnier P, Mami-Chouib F, Gautier E, Echchakir H, Angevin E, Chevalier T, Bataille V, Squiban P, et al. Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients. Gene Ther. 2003;10:386–95. doi:10.1038/sj.gt.3301928. PMID:12601393.
   PubMed Web of Science ®Google Scholar
• Facciabene A, Aurisicchio L, Elia L, Palombo F, Mennuni C, Ciliberto G, La Monica N. Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile entertoxin elicit antigen-specific immune responses and antitumor effects. Vaccine. 2007;26:47–58. doi:10.1016/j.vaccine.2007.10.060. PMID:18055074.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Ishibashi D, Yamaguchi N, Yoshikawa D, Nakamura R, Okimura N, Arakawa T, Tsuji T, Katamine S, Sakaguchi S. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin. Vaccine. 2006;5:2815–23. doi:10.1016/j.vaccine.2005.12.054
   Web of Science ®Google Scholar
• Croyle MA, Callahan SM, Auricchio A, Schumer G, Linse KD, Wilson JM, Brunner LJ, Kobinger GP. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J Virol. 2004;78:912–92. doi:10.1128/JVI.78.2.912-921.2004. PMID:14694122.
   PubMed Web of Science ®Google Scholar
• Zakhartchouk AN, Viswanathan S, Mahony JB, Gauldie J, Babiuk LA. Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice. J Gen Virol. 2005;86:211–15. doi:10.1099/vir.0.80530-0. PMID:15604448
   PubMed Web of Science ®Google Scholar
• Croyle MA, Cheng X, Sandhu A, Wilson JM. Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo. Mol Ther. 2001;4:22–28. doi:10.1006/mthe.2001.0411. PMID:11472102.
   PubMed Web of Science ®Google Scholar
• Mutwiri G, Watts T, Lew L, Beskorwayne T, Papp Z, Baca-Estrada ME, Griebel P. Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep. Immunol. 1999;97:455–61. doi:10.1046/j.1365-2567.1999.00791.x
   PubMed Web of Science ®Google Scholar